Deemed “insufficient” by the High Authority of Health (HAS), some of these drugs such as Tanakan used for memory problems in the elderly presents particularly expensive expenses for Health Insurance.
The list of 200 drugs whose reimbursement rate drops from 35% to 15% is not yet final. Pharmaceutical companies now have one month to contest the reduction in the reimbursement rate for drugs or submit their observations.
Here are some examples of the 200 drugs communicated this Friday, February 26 by Health Insurance:
Abufene, Gelox, Fongamil, Toplexil, Vasobral….
Loading-widget
